false
0001833498
0001833498
2026-11-13
2026-11-13
0001833498
MDAI:CommonStockParValue0.0001PerShareMember
2026-11-13
2026-11-13
0001833498
MDAI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf2.75PerShareMember
2026-11-13
2026-11-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 13, 2026
SPECTRAL
AI, INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-40058 |
|
85-3987148 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification No.) |
2515 McKinney Avenue, Suite 1000
Dallas, Texas |
|
75201 |
| (Address of principal executive offices) |
|
(Zip Code) |
(972) 499-4934
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
MDAI |
|
The Nasdaq Stock Market LLC |
| Redeemable Warrants, each whole warrant exercisable for one share of Common Stock, at an exercise price of $2.75 per share |
|
MDAIW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. Entry into a Material Definitive
Agreement
On November 13, 2026, Spectral
AI, Inc. (the “Company”) entered into the Standby Equity Purchase Agreement (“SEPA”)
with YA II PN, LTD, a Cayman Islands exempt limited company (“Yorkville”), which amends the Standby Equity Purchase
Agreement previously entered into on March 19, 2024, pursuant to which the Company has the right to sell to Yorkville up to $15.0 million
of its shares (“Shares”) of common stock, par value $0.0001 (“Common Stock”), subject
to certain limitations and conditions set forth in the SEPA, from time to time during the term of the SEPA. Sales of the shares of Common
Stock to Yorkville under the SEPA, and the timing of any such sales, are at the Company’s option, and the Company is under no obligation
to sell any shares of Common Stock to Yorkville under the SEPA.
Upon the satisfaction of the
conditions to Yorkville’s purchase obligation set forth in the SEPA , including having a registration statement registering the
sale of the shares of Common Stock issuable under the SEPA filed with the Securities and Exchange Commission (the “SEC”),
the Company will have the right, but not the obligation, from time to time at its discretion until the SEPA is terminated to direct Yorkville
to purchase a specified number of shares of Common Stock (“Advance”) by delivering written notice to Yorkville
( “Advance Notice”). While there is no mandatory minimum amount for any Advance, it may not exceed the greater
of (i) an amount equal to 100% of the average of the daily traded amount during the five consecutive trading days immediately preceding
an Advance Notice, and (ii) 500,000 shares of Common Stock.
The shares of Common Stock
purchased pursuant to an Advance delivered by the Company will be purchased at a price equal to 97% of the lowest daily VWAP of the shares
of Common Stock during the three consecutive trading days commencing on the date of the delivery of the Advance Notice, other than the
daily VWAP on a day in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or
there is no VWAP on the subject trading day. The Company may establish a minimum acceptable price in each Advance Notice below which the
Company will not be obligated to make any sales to Yorkville. “VWAP” is defined as for any trading day or specified
period, the volume weighted average price of the shares of Common Stock on the principal market, for such period as reported by Bloomberg
L.P. through its “AQR” function.
The sale and issuance of the
shares of Common Stock under the Advances is being made pursuant to the Company’s registration statement on Form S-3 (file number
333-282681) (the “Registration Statement”), filed with the SEC on October 16, 2024 and declared effective on
October 31, 2024, the base prospectus dated October 31, 2024 thereunder and the Company’s prospectus supplement relating to the
SEPA, which is being filed with the SEC on November 19, 2026, that forms part of the Registration Statement.
Under the applicable Nasdaq
Stock Market (“Nasdaq”) rules, in no event may the Company issue to Yorkville under the SEPA more than 6,433,767
shares of Common Stock, which number of shares is equal to 19.99% of the shares of Common Stock outstanding immediately prior to the execution
of the SEPA (the “Exchange Cap”), unless (i) the Company obtains stockholder approval to issue shares of Common
Stock in excess of the Exchange Cap in accordance with applicable Nasdaq rules, or (ii) the average price per share paid by Yorkville
for all of the shares of Common Stock that the Company directs Yorkville to purchase from the Company pursuant to the SEPA, if any, equals
or exceeds $1.35 per share (representing the lower of (a) the official closing price of the Common Stock on Nasdaq immediately preceding
the execution of the SEPA and (b) the average official closing price of the Common Stock on Nasdaq for the five consecutive trading days
immediately preceding the execution of the SEPA , adjusted as required by Nasdaq) so that the Exchange Cap limitation will not apply to
issuances and sales of Common Stock pursuant to the SEPA). Moreover, the Company may not issue or sell any shares of Common Stock to Yorkville
under the SEPA which, when aggregated with all other shares of Common Stock then beneficially owned by Yorkville and its affiliates (as
calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and Rule 13d-3 thereunder), would result in Yorkville beneficially owning more than 4.99% of the outstanding shares of Common Stock.
The Company will control the
timing and amount of any sales of shares of Common Stock to Yorkville. Actual sales of shares of Common Stock to Yorkville as an Advance
under the SEPA will depend on a variety of factors to be determined by the Company from time to time, which may include, among other things,
market conditions, the trading price of the Company’s Common Stock and determinations by the Company as to the appropriate sources
of funding for our business and operations.
The SEPA will automatically
terminate on the earliest to occur of (i) the 24-month anniversary of the date of the SEPA or (ii) the date on which the Yorkville shall
have made full payment of Advances pursuant to the SEPA. The Company has the right to terminate the SEPA at no cost or penalty upon five
(5) trading days’ prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which shares of
Common Stock need to be issued and the Company has paid all amounts owed to Yorkville pursuant to the SEPA. The Company and Yorkville
may also agree to terminate the SEPA by mutual written consent. Neither the Company nor Yorkville may assign or transfer our respective
rights and obligations under the SEPA without the prior written consent of the other party, and no provision of the SEPA may be modified
or waived by the Company or Yorkville other than by agreement of the parties.
As consideration for the SEPA,
the Company paid Yorkville, a structuring fee in the amount of $15,000.
The SEPA contains customary
representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants
contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the
parties to such agreements and may be subject to limitations agreed upon by the contracting parties.
The net proceeds under the
SEPA to the Company will depend on the frequency and prices at which the Company sells its shares of Common Stock to Yorkville. The Company
expects that any proceeds received from such sales to Yorkville will be used for working capital and general corporate purposes.
The foregoing description
of the SEPA does not purport to be complete and is qualified in its entirety by reference to such document, which is filed as Exhibit
10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
A copy of the legal opinion
of Cozen O’Connor, relating to the validity of the Shares in connection with the SEPA is filed as Exhibit 5.1 to this Current Report
on Form 8-K and is incorporated herein by reference.
This Current Report on Form
8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of Common Stock, nor shall there be any sale
of shares of Common Stock in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or other jurisdiction.
This report contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities
Act of 1933, as amended, and Section 21E of the Exchange Act. Such forward-looking statements may include statements related to, the intended
use of proceeds from the SEPA and other statements that are not statements of historical fact and, in some cases, may be identified by
words like “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,”
“future,” “will,” “should,” “would,” “seek” and similar terms or phrases.
The forward-looking statements contained in this press release are based on management’s current expectations, which are subject
to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s
control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking
statements are more fully discussed in the Company’s periodic filings with the SEC, including the risk factors described under the
heading “Risk Factors” in the Company’s annual report on Form 10-K for the year ended December 31, 2025 filed with the
SEC on March 25, 2026, and other documents subsequently filed with or furnished to the SEC.
Any forward-looking statement
made in this Current Report on Form 8-K speaks only as of the date hereof. Factors or events that could cause the Company’s actual
results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict
all of them. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether
as a result of new information, future developments or otherwise.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Description |
| 5.1 |
|
Opinion of Cozen O’Connor |
| 10.1 |
|
Standby Equity Purchase Agreement, dated November 13. 2026, between Spectral AI, Inc. and YA II PN, Ltd. |
| 23.1 |
|
Consent of Cozen O’Connor (contained in Exhibit 5.1). |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 19, 2026
| |
SPECTRAL AI, INC. |
| |
|
|
| |
By: |
/s/ Vincent Capone |
| |
Name: |
Vincent Capone |
| |
Title: |
Chief Executive Officer |